Organ Transplantation : A New Era of Infection Control & Ethics
Leading research on infection management in transplant patients, Dr. Almaghrabi has shaped novel approaches that reduce complications and enhance patient outcomes. Her studies on gut microbiome in liver transplant patients and infections in organ donors have influenced clinical practices prioritizing safety and long-term patient health. 'In every case, we aim for not just survival but a quality of life that our patients deserve,' she explains. These projects have provided more profound insights into infection dynamics, paving the way for safer, more effective treatments.
Dr. Almaghrabi's dedication to improving infection control is evident in her recent discovery of Stenotrophomonas Riyadhensis, a new bacterial species identified through whole-genome sequencing (WGS). This discovery addresses the growing global issue of antibiotic resistance, a particular challenge in high-risk transplant patients. 'Precision is our greatest ally against antibiotic resistance,' Dr. Almaghrabi explains. 'By understanding the specific behaviors of pathogens, we're pioneering ways to keep our patients safer and our care more effective.'
One of her close department colleagues emphasizes the significance of her work: 'Dr. Almaghrabi's leadership in leveraging WGS has redefined our infection control standards at KFSHRC, enhancing accuracy in diagnostics and strengthening patient safety.'
Her commitment to advancing patient care is also shaped by the challenges she faced throughout her career. One memorable case from her residency involved a young patient with a rapidly spreading skin infection. 'Despite our efforts, the infection progressed, and we had to make the difficult decision to intubate,' she recalls. The experience, though profoundly emotional, strengthened her dedication to improving patient outcomes.
Dr. Almaghrabi's approach is deeply grounded in ethics, particularly patient safety and equitable care. She has co-authored studies that examine the ethical challenges surrounding organ transplantation, including issues of socio-economic disparities in access to care. 'We must be vigilant about the implications of each choice in medicine,' she asserts. 'Our role goes beyond clinical care; we are advocates for ethical standards and patient welfare.'
As a veteran educator at KFSHRC, Dr Almaghrabi teaches residents and fellows the importance of pairing technical excellence with empathy. 'Teaching allows me to stay at the forefront of advancements while instilling responsibility in the next generation,'' she explains. For her, training future physicians is a blend of building technical expertise and nurturing a commitment to patient-centred care. 'Medicine is not just about procedures; it's about understanding the patient's journey and treating each case with empathy and respect,' she shares.
As technology advances, Dr. Almaghrabi is particularly enthusiastic about the transformative power of artificial intelligence (AI) in infectious disease management for complex diagnostics in transplant patients. 'AI offers unprecedented accuracy and speed, both of which are critical in handling infections in transplant patients,' she remarks.
Outside of her professional life, Dr. Almaghrabi finds balance through yoga and time in nature. Dr. Almaghrabi's greatest reward comes from serving her country and inspiring young Saudis to pursue their medical dreams. 'Helping patients recover after challenging interventions drives me,' she reflects. 'It's a privilege to serve, and each patient's journey reaffirms the impact we can have, not only in healing but in encouraging the next generation to dream, strive, and achieve.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Mid East Info
5 days ago
- Mid East Info
On World Organ Donation Day KFSHRC Announces 10 Kidney Exchange Transplants Completed in 48 Hours - Middle East Business News and Information
Riyadh: King Faisal Specialist Hospital and Research Centre (KFSHRC) successfully performed 10 kidney exchange transplants over two consecutive days, setting a global record for the highest number of such procedures conducted within a two-day span at a single center, coinciding with World Organ Donation Day on August 13. This milestone reinforces KFSHRC's position as a global leader in organ transplantation. This accomplishment reflects the hospital's high clinical readiness, the seamless coordination of its multidisciplinary medical teams, and its advanced systems for managing donor-recipient matching, alongside its extensive experience in executing complex transplant procedures. All of these factors enable KFSHRC to carry out this type of exchange transplantation with precision and within an exceptionally short timeframe. Paired kidney transplantation is an innovative approach that matches donor–patient pairs for mutual exchange. In this system, each donor gives a kidney to a patient with whom they have no direct relation, while their own relative receives a kidney from another donor. The process significantly improves compatibility rates and offers new hope to patients who face challenges in finding a suitable match within their families. Last year, KFSHRC celebrated a major milestone by completing more than 500 paired kidney transplants since the program was launched in 2011. Since launching its organ transplantation program in 1981, the hospital has successfully performed over 5,000 kidney transplants, placing it among an elite group of global transplant centers. In 2024, the hospital conducted 80 pediatric kidney transplants, the highest annual volume reported worldwide. This makes KFSHRC's pediatric kidney transplant program the largest of its kind compared to leading centers in the United States and Europe. This remarkable achievement underscores KFSHRC's commitment to its vision of being the provider of choice for specialized healthcare. By leveraging its skilled workforce, advanced technologies, and the integration of research and clinical programs, the hospital aims to deliver world-class treatment experiences both locally and globally, while enhancing the Kingdom's position as a leader in organ transplantation. KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world's top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.


Mid East Info
09-07-2025
- Mid East Info
A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
In a rare example of a lifelong bond between a patient and a healthcare institution, King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh has continued to support a patient since infancy, providing 22 years of continuous care for a rare genetic blood clotting disorder, ultimately culminating in a liver transplant—the first of its kind globally for this particular condition. When the early signs of illness appeared during the patient's first months of life, KFSHRC teams raced against time to stabilize her condition. She was diagnosed with a congenital deficiency in plasminogen, a protein essential for dissolving blood clots, resulting in fibrous deposits that posed serious threats to her tissues and organs. The complexity of her case posed both medical and quality-of-life challenges, requiring a comprehensive, multidisciplinary care system. This extended beyond medical treatment to include all facets of life-supporting care. Teams from nursing, nutrition, and information technology joined hematology and transplant specialists to ensure the young girl's well-being. In a reflection on the early days, the patient's father said: 'My daughter suffered from the moment she was born. She cried constantly and couldn't nurse. We lived in continuous worry with no clear answers until God opened a door of hope. Today, thanks to God first, and then to the remarkable healthcare capabilities provided by the Government of the Custodian of the Two Holy Mosques and His Royal Highness the Crown Prince, may God preserve them, we witness our daughter's recovery from this rare disease after two decades of struggle.' Throughout the years of treatment, the patient relied on regular intravenous doses of plasminogen, along with eye drops to reduce the disease's effect on her vision. The annual cost of treatment exceeded 6 million SAR, fully covered by the Saudi government. This reflects the Kingdom's profound commitment to human health and its investment in quality of life even in the most complex medical cases. Dr. Hazzaa Al-Zahrani, Director of Adult Hematology and Stem Cell Transplant Division at KFSHRC Riyadh and the supervising physician, explained that managing the case required a precise and long-term approach to prevent complications and ensure stability. The decision to proceed with a liver transplant came after careful consideration as an extraordinary therapeutic option for an exceptionally rare case. The success of the procedure marked a turning point in her medical journey and a beacon of hope for patients facing similar conditions worldwide. This approach is deeply rooted in the vision of King Faisal Specialist Hospital & Research Centre, which places the patient at the core of every practice and is committed to delivering integrated care where scientific expertise meets human compassion, in line with its mission to serve society at the highest standards.


Mid East Info
14-06-2025
- Mid East Info
KFSHRC Advances Smart Hospital Transformation through AI and Emerging Technologies - Middle East Business News and Information
King Faisal Specialist Hospital & Research Centre KFSHRC continues to redefine global healthcare through its Smart Hospital initiative, leveraging AI, simulation, and immersive technologies across its departments. These technologies have supported KFSHRC to enhance workforce training, clinical care, and operational efficiency. The Academic & Training Affairs (ATA) division is leading this transformation, deploying next-generation tools such as simulation labs, e-learning, and virtual reality (VR) to deliver hands-on, immersive training. These technologies allow healthcare professionals to rehearse complex procedures from emergency care to surgical planning, strengthening clinical preparedness and patient safety. The Patient Flow & Capacity Command Centre enhances operational efficiency by applying AI to forecast demand, manage resources, and monitor patient flow in real time. Since its launch, the Centre has completed over 170,000 interventions, cutting bed wait times from 32 to 6 hours and reducing emergency delays by 14%. In 2024 alone, the hospital received over 46,000 new patients and processed more than 79,000 referrals. Smart tools, such as the Noor robot, enhance the patient experience by providing real-time assistance and improving access to services. Across departments such as Radiology, Pathology, Genomics, and Oncology, AI enhances diagnosis, interpretation, early interventions and personalized care for complex diseases. Driving these innovations is KFSHRC's Centre for Healthcare Intelligence (CHI), which has developed over 20 AI applications in medical imaging, clinical decision support, and operations. In partnership with the Saudi Commission for Health Specialties, CHI also leads national AI training programs to build future-ready digital health talent. At the 2024 GAIN Summit CHI unveiled a generative AI platform to synthesize patient data, accelerate diagnostics, and streamline triage. KFSHRC ranks among Saudi Arabia's top 20 government entities in the 2025 Technology Adoption Readiness Index and received the 2024 Zimam Best AI Program Award, recognizing its leadership in AI, robotic surgery, and digital innovation. Additionally, it was included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world's top 250 Academic Medical Centres for the third consecutive year and recognised as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2025 Brand Finance rankings.